This application claims priority from prior Japanese Patent Applications No. 2023-103519, filed on Jun. 23, 2023, the entire contents of which are incorporated herein by reference.
The disclosure relates to a particle separation chip and a particle separation apparatus.
In recent years, various methods of particle separation using micro flow path have been developed. For example, the following non-patent document 1 discloses a particle separation method using hydrodynamic filtration. In the separation method, a micro flow path consisting of a main flow path and a plurality of branch flow paths branched from the main flow path is used. A specimen is introduced into the main flow path, and particles are separated between the main flow path and the branch flow path based on the size of the particles. According to the separation method, damage to the particles due to separation is minimal and the structure of the flow path may be simplified.
“Classification of Blood Cells Using Hydrodynamic Filtration,” Miyuki Matsuda, and 2 others, Journal of Electrical Engineering E, Institute of Electrical Engineers, 2008, Vol. 128, No. 10, page. 396 to 401 (Non-Patent Document 1) is an example of a related art.
The micro flow path using the Hydrodynamic Filtration described above may be usable at the laboratory level. However, they do not satisfy the high specimen processing ability (throughput) required at the practical level, e.g., in product development and clinical settings.
In view of these issues, the purpose of the present invention is to provide a particle separation chip and a particle separation apparatus that may demonstrate sufficient specimen processing capacity (throughput) at product development sites and clinical sites.
A particle separation chip according to one or more embodiments may include a substrate having a micro flow path inside, and a perforated sheet with a plurality of holes. The micro flow path includes a main flow path having an inlet at the upstream side into which a specimen containing first particles and second particles smaller than the first particles is supplied, and a first outlet at the downstream side from which a specimen containing mainly first particles is extracted, and includes a branch flow path which is connected to the main flow path at a plurality of branches along the flow direction of the main flow path, having a second outlet from which a specimen containing a second particle is extracted on the downstream side. At the plurality of branches, the main flow path and the branch flow path are connected via holes in the perforated sheets.
According to the particle separation chip of the present invention, the main flow path and the branch flow path are connected through holes in the perforated sheet at multiple branches. This enables sufficient specimen processing capacity (throughput) at product development sites and clinical sites.
A particle separation apparatus may include a particle separation chip according to one or more embodiments, a setting part on which the particle separation chip is placed, a liquid pumping section for inserting the specimen and sheath liquid respectively into a specimen inlet at the particle separation chip and sheath liquid inlet, a first collection section for the first particles connected to the first outlet, a second collection section for the second particles connected to the second outlet.
According to the particle separation apparatus, the particle separation chip is placed on the setting part, and the liquid pumping section is driven to insert the first specimen and sheath liquid. This allows smooth collection of the first and second particles from the first and second collection sections, respectively.
A particle separation chip and a particle separation apparatus for separating a plurality of particles in a liquid specimen based on the size of the particles according to one or more embodiments are described. In one or more embodiments, the particle separation chip separates a liquid specimen (first specimen) containing a first particle and a second particle smaller than the first particle into a liquid specimen (second specimen) containing primarily the first particle and a liquid specimen (third specimen) containing primarily the second particle. The first specimen is a blood specimen.
The blood specimen is, for example, whole blood or a specimen prepared from whole blood. The first particles are, for example, Circulating Tumor Cells (CTCs) in the blood, and the second particles are, for example, white blood cells, red blood cells, platelets, and nanoparticles. Nanoparticles are, for example, extracellular vesicles such as exosomes, microscopic proteins, and microscopic debris. The size of a particle is, for example, the diameter or radius of the particle, the area or perimeter length when viewed in plan view. In the following description, particle diameter refers to the diameter of a particle.
Hereinafter, for convenience, X, Y, and Z axes orthogonal to each other are added to each figure. The Z-axis direction is the height direction of the particle separation chip 1 and the particle separation apparatus 2 to be described later. The X-Y axis is parallel to the horizontal plane. In one or more embodiments, the specimen flows in the direction of the X axis, and the left side of the flow path is marked as the upstream side and the right side of the flow path is marked as the downstream side in the figure.
The configuration of the particle separation chip 1 is described referring to
The upper substrate 10 includes a plate-like member having an opposing surface 10a and an upper surface 10b parallel to the X-Y plane and with a spacing of D1 between the two surfaces. The upper substrate 10 is placed plane symmetrically in the Y-axis direction with respect to a hypothetical vertical plane VP that intersects the upper substrate 10 vertically at a central axis CA parallel to the X-axis direction. The facing surface 10a is the surface facing the lower substrate 20, which is described below, and the upper surface 10b is the top surface of the particle separation chip 1 when the particle separation chip 1 is completed.
The upper substrate 10 includes a material that allows blood specimens to flow smoothly over the surface and to be processed with high precision, such as polydimethylsiloxane (PDMS). The upper substrate 10 may also include glass, cyclo-olefin polymer (COP), cyclic olefin copolymer (COC), etc.
The main flow path 100 with a predetermined depth d1 is placed on the facing surface 10a. In addition, the four outlets 213 including through holes are formed along the right-side end of the upper substrate. The main flow path 100 and the four outlets 213 are formed, for example, by a semiconductor fabrication process. The main flow path 100 has a recessed portion in the Z-axis direction with respect to the facing surface 10a, and the bottom surface of this recessed portion is parallel to the X-Y plane. The main flow path 100 is formed by overlapping the upper substrate 10 and the lower substrate 20 to form a flow path through which the specimen may be transferred. The four outlets 213 are part of the branch flow path 200, which will be described later.
The main flow path 100 includes the inlets 101, 102, and 103 arranged on the left side of the main flow path 100, the flow paths 111 and 112, a pair of flow paths 113, a flow path 120 arranged in the center of the main flow path 100, and an outlet 104 arranged on the right side of the main flow path 100.
The Inlets 101 to 103 and the outlet 104 are formed by through holes through the upper substrate 10 in the Z-axis direction and are arranged in a row along the vertical plane VP and the central axis CA. The two outlets 213 are arranged in a row on each side of the outlet 104 along the Y-axis. The four outlets 213 are formed by through holes through the upper substrate 10 in the Z-axis direction.
The flow paths 111 and 112 extend in the X-axis direction and are arranged along the central axis CA. The width of flow paths 111 and 112 is consistent. The upstream end of the flow path 111 leads to the inlet 101. The downstream end of the flow path 111 leads to the flow path 120. The center of the flow path 111 leads to the inlet 102.
The Inlet 103 is arranged at the left of the inlet 101. The left-side end of flow path 112 is connected to the inlet 103. A pair of the flow paths 113 are branched from flow path 112 along both sides of the vertical plane VP in the Y-axis direction. The pair of the flow paths 113 bypass the inlets 101 and 102 and connect the flow path 112 to the flow path 111. The right-hand end of the pair of the flow paths 113 connects at an angle to the flow path 111 between the inlets 102 and the flow path 120. The width of the pair of flow paths 113 is consistent.
The flow path 120 extends in the X-axis direction and is located on the central axis CA. The width in the Y-axis direction of the flow path 120 gradually increases in the left portion of the flow path 120 as it progresses from the connection of flow paths 111 and 120 to the center. The width in the Y-axis direction of flow path 120, except for the left side portion, is consistent and wider than the width of flow paths 111 to 113. The right-side end of flow path 120 is connected to outlet 104.
The size of the main flow path 100 may be set, for example, as follows.
When the external shape of the particle separation chip 1 is 150 mm square in plan view, the length of the flow path 120 in the X-axis direction may be set to 150 mm or less, for example. The width of the flow path 120 in the Y-axis direction may be set to about one-third of the length of one side of the outline, for example, 50 mm or less.
The width of the flow path 120 in the Y-axis direction may be set to 500 μm or more, for example, when 5 mL of whole blood is flowed into the particle separation chip 1 as a blood specimen in a single particle separation process. According to the embodiment, if the Y-axis width of the flow path 120 is 500 μm, for example, the time required to flow 5 mL of whole blood is 200 minutes, and the throughput of the particle separation process is 25 μL/min. If the Y-axis width of flow path 120 is 50 mm, for example, the time required to flow 5 mL of whole blood is 2 minutes, and the throughput of the particle separation process is 2.5 mL/min. If a smaller amount of whole blood is flowed to the particle separation chip 1 during one particle separation process, the Y-axis width of flow path 120 may be set to 100 μm or more, for example. Throughput is the amount of specimen that is subjected to the particle separation process per unit of time. If the specimen is a blood specimen, it is the amount of undiluted whole blood that is subjected to the particle separation process per unit of time.
The depth d1 of the flow path 120 (the height in the Z-axis direction of the recess corresponding to the flow path 120 formed in the upper substrate 10) may be set larger than the particle diameter of the first particle so that the first particle may be transferred in the flow path 120. When the first particle is a CTC, the depth d1 of the flow path 120 may be set to, for example, 100 μm or greater, and when the first particle is a nanoparticle, the depth d1 of the flow path 120 may be set to, for example, 50 nm or greater. Since the flow path 120 is formed by a semiconductor fabrication process, the depth d1 of the flow path 120 may be set to 1 mm or less, for example.
The depth of the flow paths 111 to 113 may also be set for the same reason as the depth of flow path 120, for example, between 50 nm and 1 mm.
The lower substrate 20 includes a plate-like member having an opposing surface 20a and a lower surface 20b parallel to the X-Y plane, with a spacing of D2 between the two surfaces. The lower substrate 20 is placed plane symmetrically in the Y-axis direction with respect to a hypothetical vertical plane VP that intersects the lower substrate 20 vertically at a central axis CA parallel to the X-axis direction. The facing surface 20a is the surface facing the upper substrate 10, and the lower surface 20b is the surface that will be the lower surface of the particle separation chip 1 when the particle separation chip 1 is completed.
The lower substrate 20 contains a material that allows blood specimens to flow smoothly over its surface and to be processed with high precision. Like the upper substrate 10, the lower substrate 20 according to one or more embodiments includes, for example, polydimethylsiloxane (PDMS). The lower substrate 20 may also include glass, cyclo-olefin polymer (COP), cyclic olefin copolymer (COC), etc.
A branch flow path 200 of a predetermined depth d2 is formed on the facing surface 20a. The branch flow path 200 is formed, for example, by a semiconductor fabrication process. The branch flow path 200 has a recessed portion in the Z-axis direction with respect to the facing surface 20a, and the bottom surface of the recessed portion is parallel to the X-Y plane. The branch flow path 200 forms a flow path when the upper substrate 10 and the lower substrate 20 are superimposed on each other, allowing specimens to be transferred through it.
Branch flow path 200 includes a plurality of flow paths 201, two relay flow paths 211, and four relay flow paths 212. The branch flow path 200 also includes the four outlets 213 shown in
A plurality of flow paths 201 extend parallel to the Y-axis direction and are aligned in the X-axis direction at predetermined intervals. The length of each flow path 201 in the Y-axis direction becomes shorter as it proceeds to the right in the X-axis direction. In other words, the overall outline of the plurality of flow paths 201 is trapezoidal in plan view.
Two relay flow paths 211 are located at one end and the other end of the plurality of flow paths 201, respectively, and are connected to the plurality of flow paths 201. The relay flow paths 211 extend so that as they proceed to the right side of the main flow path 100 (see
The size of the branch flow paths 200 may be set, for example, as follows.
When the external shape of the particle separation chip 1 is 150 mm square in plain view, the Y-axis length of the plurality of flow paths 201 may be set to be less than 150 mm, for example. The Y-axis length of the plurality of flow paths 201 may all be set longer than the Y-axis width of the flow path 120.
The width (length in the X-axis direction) of the flow path 201 may be set larger than the particle diameter of the second particle so that the second particle may be transferred in the flow path 201. If the second particles are white blood cells, red blood cells, and platelets, the width of the flow path 201 may be set to, for example, 100 μm or greater, and if the second particles are nanoparticles, the width of the flow path 201 may be set to, for example, 50 nm or greater. The width of the flow path 201 may be set to less than 1 mm, for example, to allow a sufficient number of flow paths 201 to be placed.
The number of multiple flow paths 201 may be set between 2 and 1500.
According to the inventors' study, when the width of the flow path 201 is 100 μm and the spacing between adjacent flow path 201 is 50 μm, about 150 flow paths 201 may be formed. According to the semiconductor fabrication process, the width and spacing of the above flow paths 201 may be further reduced to about 1/100, making it possible to form 15,000 flow paths 201. Two or more flow paths 201 are placed to realize the Hydrodynamic Filtration (HDF) method described below.
The depth d2 of the flow path 201 (the height in the Z-axis direction of the recess corresponding to the flow path 201 formed in the lower substrate 20) may also be set larger than the diameter of the second particles so that the second particles may be transferred in the flow path 201. If the second particles are white blood cells, red blood cells, and platelets, the depth d2 of the flow path 201 may be set to, for example, 100 μm or greater, and if the second particles are nanoparticles, the depth d2 of the flow path 201 may be set to, for example, 50 nm or greater. Since the flow path 201 is formed by a semiconductor fabrication process, the depth d2 of the flow path 201 may be set to 1 mm or less, for example.
The depth of the relay flow paths 211 and 212 may also be set for the same reason as the depth of the flow path 201, for example, between 50 nm and 1 mm.
The perforated sheet 30 is rectangular in plain view and is a thin-film sheet. The perforated sheet 30 includes a plurality of holes 31 that penetrate the perforated sheet 30 in the Z-axis direction. As described below, the second particles flowing in the main flow path 100 move through the holes 31 of the perforated sheet 30 to the branch flow path 200. The perforated sheet 30 contains a material that allows the blood specimen to flow smoothly across the surface, allows the holes 31 to be formed with high precision, and is not easily damaged. The perforated sheet 30 according to one or embodiments includes nickel, for example. The perforated sheet 30 does not necessarily have to be metal and may include glass or PDMS.
The size of the perforated sheet 30 may be set, for example, as follows.
The thickness of the perforated sheet 30 may be set, for example, between 1 μm and 1 mm so that separation of the second particles by the Hydrodynamic Filtration is achieved. According to the inventors' study, even if the thickness of the perforated sheet 30 is set to 1 mm, the fluid resistance on the second particles passing through the holes 31 by the perforated sheet 30 is almost negligible. The hole diameter of the holes 31 may be set, for example, to be between 30 nm and 100 μm, more preferably between 50 nm and 100 μm, so that the first particles may smoothly proceed downstream in the flow path 120 of the main flow path 100.
The porosity, which is the percentage of the area of the holes 31 in the perforated sheet 30, may be set greater than 0% and less than 50%, for example, to maintain the strength of the perforated sheet 30. In one or more embodiments, the size and shape of all the holes 31 formed in the perforated sheet 30 are the same as each other, and all the holes 31 are evenly distributed in the perforated sheet 30. Therefore, the perforation rate of the perforated sheet 30 is substantially the same value as each other at a plurality of branches B (see
The perforation ratio of the perforated sheet 30 may be different from each other at the plurality of branches B. In this case, the perforated sheet 30 may have a different number of holes 31 and a different diameter of holes 31 at a plurality of branches B. The perforated sheet 30 may have a different number of holes 31 in different regions within one branch B, and the diameters of the holes 31 may be different from each other.
The length of the perforated sheet 30 may be set longer than the constant width of the flow path 120 in the Y-axis direction of the upper substrate 10. The X-axis length of the perforated sheet 30 may be set longer than the X-axis length of the entire plurality of flow paths 201 of the lower substrate 20.
The upper substrate 10 shown in
The main flow path 100 includes a recess formed in the facing surface 10a of the upper substrate 10 and the facing surface 20a of the lower substrate 20 opposite this recess. The branch flow path 200 includes a recess formed in the facing surface 20a of the lower substrate 20 and the facing surface 10a of the upper substrate 10 opposite this recess. The main flow path 100 and the branch flow path 200 constitute a micro flow path 1a. A micro flow path is generally a flow path with a depth and width of 10 μm to 1 mm. The outlet 213 of the upper substrate 10 overlaps the right-side end of the relay flow path 212 of the lower substrate 20 in the X-axis direction, and the outlet 213 is connected to the relay flow path 212.
In the X-axis direction, the perforated sheet 30 is placed to cover the entirety of the plurality of flow paths 201 of the branch flow path 200. In the Y-axis direction, the perforated sheet 30 is positioned inside the shortest flow path 201.
Referring now to
A liquid specimen containing a first particle and a second particle smaller than the first particle is poured into inlet 101 as the first specimen. Sheath liquid is poured into inlets 102 and 103. For example, Cellpack (registered trademark) manufactured by Sysmex Corporation may be used as the sheath liquid. From outlet 104, a liquid specimen containing mainly first particles is withdrawn as a second specimen. From the plurality of outlets 213, a liquid specimen containing mainly the second particles is taken out as a third specimen.
As shown in
As shown in
As shown in
In the area where flow path 120 and flow path 201 overlap in plan view, the recesses on the side of the flow path 120 and the recesses on the side of the flow path 201 are connected in the Z-axis direction. The intersection surface of the flow path 120 and the flow path 201 is an opening, and a perforated sheet 30 is placed in this opening to close the opening. The point corresponding to the opening on the intersection surface of the flow path 120 and the flow path 201 where the perforated sheet 30 is placed is the branch B. Therefore, the area of the branch B is equal to the area of the opening in the intersection surface of the flow path 120 and the flow path 201. The branch flow path 200 is connected to the main flow path 100 at a plurality of branches B along the flow direction (X-axis direction) of the main flow path 100. The perforated sheet 30 is arranged to span the plurality of branches B.
In one or more embodiments, the plurality of branches B have the same shape as each other and are placed at the same Y-axis and Z-axis positions as each other. The plurality of branches B are aligned so that the spacing in the X-axis direction is the same as each other. However, the plurality of branches B may be placed to be spaced apart from each other in the X-axis direction between the inlet 101 and the outlet 104 of the main flow path 100. For example, the plurality of branches B may have different shapes and different areas from each other. The plurality of branches B may be placed at different Y-axis locations from each other or at different Z-axis locations from each other. The plurality of branches B may be spaced differently from each other.
When the first specimen flowing downstream through the flow path 120 passes through the branch B, the second particles contained in the first specimen flow through the holes 31 of the perforated sheet 30 to the flow path 201. The third specimen containing the second particles is then taken out of the outlet 213 (see
As shown in the lower part of
In
As described in
If the flow rate in flow path 120 flowing upstream to one flow path 201 is Qm and the flow rate into that flow path 201 is Qs, the relationship between flow rate Qm and flow rate Qs may be expressed by the following EQ.(1) using the liquid removal rate a at the branch B concerned.
Qs=Qm×a EQ.(1)
The liquid removal rate a at the branch B may be set to a value where the second particles flow into the branch flow path 200 and the first particles flow into the main flow path 100. According to the Hydrodynamic Filtration, the height h of the liquid portion of the first specimen that flows into each flow path 201 is determined by the liquid removal rate a. Therefore, in this method, the liquid removal rate a is set so that the height h of the liquid portion of the first specimen is smaller than the radius of the first particle and larger than the radius of the second particle. This causes the first particles to be transferred downstream along the flow of the first specimen. The second particles are separated into the respective flow paths 201 by the liquid portion of the first specimen in the height h range.
According to one or more embodiments, the liquid removal rate a at all branches B may be set to substantially the same value as each other. When the liquid removal rate a in each flow path 201 is equal to each other, the height h of the liquid portion of the first specimen flowing into each flow path 201 is also equal to each other. This allows separation of a second particle of a constant size at a plurality of branches B in a full and uniform manner.
Here, the liquid removal rate a at branch B is determined by the fluid resistance of branch flow path 200 from branch B to outlet 213 (see
According to one or more embodiments, the size of the relay flow paths 211 and 212 (see
The liquid removal rate a at the plurality of branches B may all be set to be greater than 0% and less than 50%. This allows a second particle having a particle diameter smaller than the depth d1 of the flow path 120 to be separated into the flow path 201.
According to one or more embodiments, the holes 31 in each of the perforated sheets 30 placed at the branch B may form a flow of specimen moving the second particle from the flow path 120 of the main flow path 100 to the flow path 201 of the branch flow path 200, as shown by the bold arrows at the positions of the holes 31 in
Thus, the second particles may be efficiently separated into flow path 201 without clogging, and the throughput of particle separation may be efficiently increased by increasing the flow rate of the main flow path 100 and branch flow path 200.
According to one or more embodiments, the particle diameter of the second particle that is separated into the flow paths 201 is not determined by the relationship between the hole diameter of the holes 31 of the perforated sheet 30 and the particle diameter of the second particle, but by the height h based on the liquid removal rate a. In other words, the perforated sheet 30 is not used as a filter to separate the second particles from the first specimen by the holes 31, but to spread the flow of the second particles toward the flow path 201, as described above. Therefore, the hole diameter of hole 31 may, for example, be larger than the diameter of the second particles to be separated.
Returning to
Next, the particle separation apparatus 2, which separates the first particles from the second particles, is described.
Particle separation apparatus 2 includes a particle separation chip 1, a fixed section 40, three inlet nozzles 51 to 53, five outlet nozzles 54 and 55, a liquid pumping section 61 to 63, a first collection section 64, and four second collection sections 65.
The particle separation chip 1 is cleaned and reused each time a particle separation process is performed. The particle separation chip 1 may be a replaceable particle separation chip that is replaced with a new one each time a particle separation process is performed.
The fixed section 40 includes a setting part 41 and an elevating part 42. The setting part 41 includes a flat plate 40a parallel to the X-Y plane and a frame 40b installed on the upper surface of the flat plate 40a. In plan view, an opening is formed in the center of the frame 40b, which is approximately the same size as the outer shape of the particle separation chip 1, and the particle separation chip 1 is installed in this opening. The elevating part 42 is supported by the elevating mechanism 2b (see
The upper ends of the inlet nozzles 51 to 53 are connected via tubing to the liquid pumping section 61 to 63, respectively. The liquid pumping sections 61 to 63 are, for example, syringe pumps. The liquid pumping section 61 is capable of pumping a predetermined amount of the first specimen to the inlet nozzle 51 at a predetermined rate. The liquid pumping sections 62 and 63 are capable of pumping a predetermined amount of sheath liquid to the inlet nozzles 52 and 53, respectively, at a predetermined rate.
The top end of the outlet nozzle 54 is connected via tubing to the first collection section 64. The top ends of the four outlet nozzles 55 are each connected via tubing to the second collection section 65. The first collection section 64 and the four second collection sections 65 are containers for collecting specimens. A liquid pumping section including a syringe pump may be placed in the tubing connecting the outlet nozzle 54 to the first collection section 64 to pump the second specimen to the first collection section 64. A liquid pumping section including a syringe pump may be placed in the tubing connecting the outlet nozzle 55 to the second collection section 65 to send the third specimen to the second collection section 65.
When the particle separation process is performed, the particle separation chip 1 is placed in the opening of the frame 40b, and the top surface of the particle separation chip 1 (upper surface 10b of the upper substrate 10) is held downward by the arm 42a as the elevating part 42 moves downward. This fixes the particle separation chip 1. Inlet nozzles 51 to 53 are then connected to the inlets 101 to 103 of the particle separation chip 1, respectively, and outlet nozzles 54 and 55 are connected to the outlets 104 and 213 of the particle separation chip 1, respectively.
In this state, liquid pumping section 62 sends sheath liquid to flow path 111 (see
The cell detection system 5 includes a particle separation apparatus 2, a stain concentration device 3, and an imaging flow cytometer 4. The cell detection system 5 is a system for detecting the first particles (e.g., CTCs) in a blood specimen collected from an examinee.
The particle separation apparatus 2 shown in
The particle separation apparatus 2 separates the blood specimen using the particle separation chip 1 to obtain a second specimen containing the first particles.
The stain concentration device 3 performs a staining process based on the second specimen obtained by the particle separation apparatus 2 to stain the first particles contained in the second specimen. The imaging flow cytometer 4 captures an image of the particles contained in the second specimen that have undergone the staining process. An operator, such as a physician or laboratory technician, refers to the captured image of the imaging flow cytometer 4 to determine the presence or absence of the first particle (e.g., CTC) in the blood specimen collected from the examinee.
Next, specific examples according to one or more embodiments are described. In the following examples, the first specimen is whole blood collected from an examinee. The first particle is a cell to be acquired (target cell) and is a Circulating Tumor Cell (CTC) in the blood. The second particles are the cells to be removed (non-target cells) and are white blood cells, red blood cells, and platelets. The inventors created a particle separation chip 1 by combining the chip and perforated sheet described in
As shown in
The depth of the branch flow path 200 is 0.1 mm. The distance from the leftmost end of the plurality of flow paths 201 to the right-side end of the region of consistent width in the Y-axis direction of the flow path 120 is Lmain. The number of the plurality of flow paths 201 is n. The serial number of the leftmost flow paths 201 is 1, and the serial number of the rightmost flow path 201 is n. The lengths of the first and nth flow path 201 protruding in the Y-axis direction relative to flow path 120 are L1 and Ln, respectively. The width (length in the X-axis direction) of the flow path 201 is w, and the distance between two adjacent flow paths 201 is v.
The length of the perforated sheet 30 in the X-axis direction is 30 mm, and the width of the perforated sheet 30 in the Y-axis direction is 6 mm. As shown in
Hereafter, four types of chips C1 to C4 consisting of the upper substrate 10 and lower substrate 20 are created by varying the distance Lmain, number n, length L1, Ln, width w and spacing v, as shown in
As shown in
In the first example, four different particle separation chips 1 are installed in the particle separation apparatus 2 described above, and a first specimen is run through each particle separation chip 1 to investigate the removal rate of red blood cells and white blood cells.
The upper part of
As shown in the upper row of
In the first example, 1 mL of the above three types of first specimens are flowed separately from inlet 101 at 100 μL/min in particle separation chips CP1 to CP4. The throughput of whole blood for the three types of first specimens (whole blood with no dilution, 1.5× dilution of whole blood, and 2× dilution of whole blood) is 100 μL/min, 67 μL/min, and 50 μL/min, respectively. The sheath liquid flows from inlet 102 at 900 μL/min and from inlet 103 at 2000 μL/min. The time for pumping the first specimen to the inlets 101 to 103 is 10 minutes for any first specimen. In each particle separation chip CP1 to CP4, the second specimen is collected from the first collection section 64 (see
Next, the number of cells (red blood cells and white blood cells) in the three first specimens and the second specimen collected with each particle separation chip CP1 to CP4 is obtained by EQ.(2) below.
Cell count=cell concentration (cells/mL)×liquid volume (mL) EQ.(2)
Here, the cell concentration is measured using a blood cell counter (XN series) manufactured by Sysmex Corporation or blood cell counter. The liquid volume is measured from the weight using an electronic scale.
Then, based on the number of cells (red blood cells and white blood cells) obtained by EQ.(2) above for each combination of the first specimen and particle separation chips CP1 to CP4, the red blood cell removal rate and white blood cell removal rate are then calculated by EQ.(3) and (4) below.
Red blood cell removal rate={1−(the number of red blood cells in the second specimen/the number of red blood cells in the first specimen)}×100(%) EQ.(3)
White blood cell removal rate={1−(the number of white blood cells in the second specimen/the number of white blood cells in the first specimen)}×100(%) EQ.(4)
In the graph in
As shown in
In the second example, one type of particle separation chip 1 is installed in the particle separation apparatus 2 described above, and the first specimen is flowed through the particle separation chip 1 to investigate the removal rate of red blood cells and white blood cells and the collection rate of CTCs.
The upper part of
As shown in the upper row of
In the second example, in the particle separation chip CP5, the entire volume (2.5 mL) of the first specimen described above is flowed separately three times at 100 μLmin from the inlet 101. The throughput of the whole blood of the first specimen is 50 μL/min at each time. The sheath liquid flows from inlet 102 at 900 μL/min and from inlet 103 at 2000 μL/min. The time for pumping the first specimen to the inlets 101 to 103 is 25 minutes at each time. The second specimen is then collected from the first collection section 64 and the third specimen from the plurality of second collection sections 65 in the particle separation chip CP5.
Next, cells (red blood cells and white blood cells) in the first and second specimens are obtained by EQ.(2) above, using the same procedure as in the first example, and the red blood cell removal rate and white blood cell removal rate are calculated by EQ.(3) and (4) above based on the number of red blood cells and white blood cells obtained.
The A549 cells in the second and third specimens collected are obtained by EQ.(2) above, and the A549 cell collection rate is calculated by EQ.(5) below based on the number of A549 cells obtained.
A549 cell collection rate=number of A549 cells in the second specimen/(the number of A549 cells in the second specimen+the number of A549 cells in the third specimen)×100(%) EQ.(5)
As shown in the upper row of
In the third example, six different type of particle separation chips 1 are installed in the particle separation apparatus 2 described above, and the first specimen is flowed through each particle separation chip 1 to investigate the cell removal rate, cell collection rate, weight ratio to flow paths 201, and collection and removal rates for each particle diameter.
The upper part of
As shown in the upper part of
In the third example, the first specimen described above flows at 110 μL/min from inlet 101 in particle separation chips CP11 to CP16. The sheath liquid flows from inlet 102 at 1400 μL/min and from inlet 103 at 1510 μL/min. The pumping time to the inlets 101 to 103 is 15 minutes. Then, in particle separation chips CP11 to CP16, a second specimen is collected from the first collection section 64 and a third specimen is collected from the plurality of second collection sections 65.
The number of cells (Jurkat cells and A549 cells) in the second and third specimens, respectively, is then calculated by the following EQ.(6).
The number of cells of a given particle diameter in a specimen=Probability of the presence of cells of a given particle diameter in the specimen×Total number of cells in the specimen×EQ.(6)
In EQ.(6) above, the probability of cell presence is obtained by the frequency in
Then, based on the number of cells (Jurkat cells and A549 cells) per particle diameter obtained by EQ.(6) above, the collection rate at a given particle diameter is calculated by EQ.(7) below.
Collection rate of cells of a given particle diameter={the number of cells of a given particle diameter in the second specimen/(the number of cells of a given particle diameter in the second specimen+the number of cells of a given particle diameter in the third specimen)}×100(%) EQ.(7)
The number of Jurkat cells and A549 cells in the second and third specimens collected is obtained by EQ.(2) above, and based on the number of Jurkat cells obtained, the removal rate of Jurkat cells is calculated by EQ.(8) below.
Jurkat cell removal rate=the number of Jurkat cells in the third specimen/(the number of Jurkat cells in the second specimen+the number of Jurkat cells in the third specimen)×100(%) EQ.(8)
Furthermore, the A549 cells in the second and third specimens collected are obtained by EQ.(2) above, and the A549 cell collection rate is calculated by EQ.(5) above based on the number of A549 cells obtained.
As shown in the top row of
As shown in the lower part of
Next, the inventors will investigate how much the throughput may be increased by using the particle separation chip with the configuration shown in the first, second, and third examples, compared to the conventional particle separation method (comparative example) described in the above non-patent document 1.
In the comparative example, 1 mL of whole blood diluted 10 times with PBS is inserted into the flow path at a flow rate of 25 μLmin, and the whole blood throughput is 2.5 μL/min. Thus, according to the comparative example, the time required for the particle separation process of 5 mL of whole blood is 2000 minutes (about 33 hours).
In contrast, the particle separation chip 1 with the configuration shown in the first, second and third examples may set the throughput of whole blood (First and second examples) and cell suspension fluid (Third example) to 50 μL/min or more. Therefore, according to the embodiment, the time required for the particle separation process of 5 mL of whole blood is less than 100 minutes. Thus, according to the first, second, and third examples, the throughput may be significantly improved compared to the comparative examples.
In
Referring to the weight ratios of waste liquids 1 to 3 and 5 to 7, the third specimen obtained from outlet 213, which is closer to the main flow path 100 (i.e., outlet 213 connected to flow path 201, which is located downstream of the main flow path 100), has a smaller weight ratio. Although the particle separation chips CP11 to CP16 are equipped with different perforated sheets PS1 to PS6 from each other, the weight ratios of the waste liquid and collected liquids obtained from the same outlet are almost the same. This indicates that when perforated sheets PS1 to PS6 are configured as in the third example, the difference in fluid resistance due to perforated sheets is almost negligible. In other words, in this case, the flow rate of the branch flow path 200 to the flow path 201 is dominated by the fluid resistance due to the flow path 201.
In
As mentioned above, the hole diameter of hole 31 generally increases in this order for perforated sheets PS1 to PS6. Referring to the graph in
In other words, although the liquid removal rate of the particle separation chip basically determines the particle diameter of particles that are not separated into the branch flow path 200 and collected through the main flow path 100, the percentage of particles of a given particle diameter collected through the main flow path 100 varies with the hole size of the perforated sheet.
Comparing the perforated sheet PS1 installed in the particle separation chip CP11 and the perforated sheet PS2 installed in the particle separation chip CP12, as shown in
<Simulation of Discharge into a Branch Flow Path>
Next, the inventors investigate the flow rate (discharge rate) of the specimen flowing from the main flow path 100 to the branch flow path 200 by simulation.
The upper part of
In this simulation, only one flow path 201 is placed in relation to flow path 120, and a perforated sheet 30 is placed at the branch B between flow path 120 and flow path 201. In this simulation, a specimen is flowed in the X-axis direction with respect to flow path 120, and the flow rate of the specimen discharged into flow path 201 through perforated sheet 30 is calculated by simulation.
The lower part of
In the lower graph in
As shown by the solid line in the lower graph in
For this reason, in one or more embodiments, the first specimen is pulled near the center in the flow path 120 by the sheath liquid flowing from the inlet 103 so that the first particles in the first specimen do not flow into the branch flow path 200 and the second particles in the first specimen flow into the branch flow path 200. This allows proper separation of the first particles from the second particles. In addition, since the first specimen is prevented from flowing more at both ends of the flow path 120, the particles are separated evenly at the branch B and the second particles may be separated efficiently.
As shown in
According to this configuration, the main flow path 100 and the branch flow path 200 are connected through the holes 31 in the perforated sheet 30 at the multiple branches B. This enables sufficient specimen processing capacity (throughput) at product development sites and clinical sites.
As shown in
Since the width of the branch flow path 200 may be widened, particle separation may be performed without clogging even when the blood specimen contains agglomerates of cells. For example, if CTCs are assumed as the first particles, CTCs may form clusters. Even in such a case, the clusters of CTCs may be collected without clogging, allowing proper diagnosis based on the CTCs contained in the blood specimen.
In addition, whole blood may be used as the first specimen without hemolyzation of unnecessary blood cells (e.g., red blood cells) in the whole blood. This eliminates the need to prepare the first specimen using a hemolytic agent and avoids damage to the particles by the hemolytic agent. In addition, the throughput of particle separation may be increased because there is no need to dilute the whole blood excessively to ensure the particle separation process.
As shown in
According to this configuration, the separated first and second particles may be collected at outlet 104 and outlet 213, respectively. Therefore, the first and second particles may be collected smoothly.
The width in the Y-axis direction (flow path width) of the flow path 120 of the main flow path 100 is between 500 μm and 50 mm or less. For example, if the amount of whole blood in the first specimen is small, the width in the Y-axis direction (flow path width) of the flow path 120 of the main flow path 100 may be between 100 μm and 50 mm or less.
By setting the flow path width of the main flow path 100 in this manner, a high particle separation throughput may be achieved. If the width of the flow path 120 in the Y-axis direction is 100 μm or greater, the first particles of 100 μm or less may flow into the flow path 120.
As shown in
According to this configuration, the length of the plurality of flow paths 201 of the branch flow path 200 may be smoothly adjusted in the in-plane direction of the lower substrate 20. Thus, the length of each flow path 201 may be smoothly set to a length suitable for the Hydrodynamic Filtration.
As shown in
According to this configuration, the specimens of the main flow path 100 near the inlet of the flow path 201 (branch B) of the branch flow path 200 may flow into the flow path 201 without bias in the width direction of the main flow path 100. Therefore, all holes 31 of the perforated sheet 30 within the inlet of the flow path 201 may be properly functional for particle separation. Thus, the particles may be efficiently separated.
The branch flow path 200 includes between two and 15,000 flow paths 201 that are connected to the main flow path 100 at the branch B.
According to this configuration, two or more flow paths 201 may be provided to achieve at least hydraulic filtration, while providing a large number of flow paths 201 in a particle separation chip 1 that is about 150 mm on all sides.
As shown in
According to this configuration, gravity may be used to insert the third specimen containing the second particle into the branch flow path 200. Thus, the efficiency of particle separation may be smoothly increased.
The particle separation chip 1 may be formed by overlapping and joining an upper substrate 10 having a recess on its lower surface for forming a main flow path 100 and a lower substrate 20 having a recess on its upper surface for forming a branch flow path 200, via a perforated sheet 30. Thus, the particle separation chip 1 may be formed simply.
As shown in
According to this configuration, as shown in
As shown in
According to this configuration, as shown in
As shown in
According to this configuration, as shown in the middle and bottom rows of
The fluid resistance of branch flow path 200 from branch B to outlet 213 (second outlet) upstream of main flow path 100 is greater than the fluid resistance of branch flow path 200 from branch B to outlet 213 (second outlet) downstream of main flow path 100.
According to this configuration, the liquid removal rate, which is the ratio of the flow rate into the branch flow path 200 to the flow rate of the main flow path 100 at each branch B, may be made closer to each other at each branch B. Thus, a second particle of a certain size may be separated.
The branch flow path 200 includes a plurality of flow paths 201 placed non-parallel to the main flow path 100 in plan view that are connected to the main flow path 100 at a plurality of branch locations B, respectively, and relay flow paths 211 and 212 that connect the plurality of flow paths 201 and an outlet 213 (second outlet). The length of the flow path 201 that is connected to the main flow path 100 at the branch B upstream of the main flow path 100 is longer than the length of the flow path 201 that is connected to the main flow path 100 at the branch B downstream of the main flow path 100.
According to this configuration, fluid resistance at the upstream branch B of the main flow path 100 may be set higher than that at the downstream branch B of the main flow path 100 with a simple configuration.
The micro flow path 1a is formed so that the liquid removal rate, which is the ratio of the flow into the branch flow path 200 to the flow in the main flow path 100 at the branch B, is the value at which the second particles flow into the branch flow path 200 and the first particles flow into the main flow path 100.
According to this configuration, the first particles may be separated from the second particles by the Hydrodynamic Filtration.
The micro flow path 1a is formed so that the liquid removal rate, which is the ratio of the flow into the branch flow path 200 to the flow in the main flow path 100 at the branch B, is substantially the same value for each other at the multiple branches B.
According to this configuration, a second particle of a certain size may be separated at a plurality of branches B in full.
The micro flow path 1a is formed so that the liquid removal rate, which is the ratio of the flow into the branch flow path 200 to the flow in the main flow path 100 at the branch B, is greater than 0% and less than 50% at the multiple branches B.
This configuration allows the second particles below the depth of the main flow path 100 to be separated into branch flow paths.
The perforated sheets PS1 to PS6 are formed so that the opening ratio, which is the ratio of the area of hole 31 to the area of the opening at the intersection of the main flow path 100 and the branch flow path 200 (the area of the branch B), is the value at which the first particles of a predetermined size are collected from the outlet 104 (first outlet) at a predetermined collection rate.
According to this configuration, as shown in the second and third examples, the first particles of the desired size may be collected at a predetermined collection rate.
The hole diameter of the holes 31 of the perforated sheets 30, PS1 to PS7 is between 30 nm and 100 μm.
According to this configuration, the perforated sheet may be configured to inhibit the first particles from flowing into the branch flow path 200 when the diameter of the first particles is 50 nm to 100 μm.
The perforated sheets 30, PS1 to PS7 are formed so that the opening ratio is greater than 0% and less than 50% at the multiple branches.
This configuration allows the strength of the perforated sheet to be maintained.
The diameter of the first particles is between 30 nm and 100 μm.
This configuration allows the separation of first particles of various sizes, from nanoparticles such as exosomes to relatively large circulating tumor cells.
The first specimen inserted through inlet 101 is a blood specimen, the first particles are circulating tumor cells, and the second particles are white blood cells, red blood cells, and platelets.
Circulating tumor cells (CTCs) in the blood leaked from tumors into the blood have been reported to be useful as a factor in cancer diagnosis and are expected to be a non-invasive test for cancer. However, it is extremely difficult to isolate and extract CTCs from blood specimens because the presence of CTCs in blood is several to several dozen per 10 mL. However, according to the above configuration, CTCs, which are rare cells, may be efficiently separated. Moreover, since no reagents are used in the particle separation process, CTCs may be separated without damage to them.
As shown in
According to this configuration, by placing the particle separation chip 1 on the setting part 41 and driving the liquid pumping sections 61-63 to insert the first specimen and sheath liquid, the first and second particles may be smoothly collected from the first collection section 64 and second collection section 65, respectively.
In order to make the fluid resistance of branch flow path 200 from branch B to outlet 213 on the upstream side greater than that of branch flow path 200 from branch B to outlet 213 on the downstream side, the length of flow path 201 in the Y-axis direction on the upstream side was set longer than that of flow path 201 in the Y-axis direction on the downstream side. However, not limited to this, the cross-sectional area of the flow path 201 at the upstream side may be set smaller than the cross-sectional area of the flow path 201 at the downstream side.
As shown in the upper row of
In setting the cross-sectional area, both the width in the X-axis direction and the height in the Z-axis direction of the flow paths 201 may be adjusted. In setting the fluid resistance, both the length in the Y-axis direction and the cross-sectional area of the plurality of flow paths 201 may be adjusted.
The plurality of flow paths 201 were formed extending on both sides of the flow path 120 of the main flow path 100, but may be formed extending on only one side of the flow path 120.
In this case, the second particles separated at the branch B move in one direction along the flow paths 201. At the opposite Y-axis end of the flow path 201, it is difficult for the specimen to flow in that one direction in the flow path 201. Therefore, it is difficult for the separation function of the second particle to be performed at the branch B, resulting in a decrease in the separation efficiency of the second particle. In contrast, when the flow path 201 extends on both sides of the flow path 120, as in the above embodiment, the separation function at the branch B is properly demonstrated and the separation efficiency of the second particle is increased.
As shown in
However, in this case, the configuration and control of the particle separation apparatus 2 becomes complicated because two liquid pumping sections 63 are needed to insert the sheath liquid into each of the two inlets 103, and the pumping volumes of the two liquid pumping sections 63 must be equal to each other. Therefore, as described above, it is preferred that only one inlet 103 be provided along the central axis CA.
One perforated sheet 30 was placed to overlap all branches B. However, this is not limited to this, and multiple perforated sheets 30 may be placed to overlap one or more branches B, respectively.
The plurality of flow paths 201 were formed in plan view, extending vertically to the flow path 120 of the main flow path 100, but may be placed in an oblique direction to the flow path 120. In this case, the length of the plurality of flow paths 201 may still be smoothly adjusted in the in-plane direction of the lower substrate 20.
In the above embodiment, as shown in
In the above embodiment, as shown in
In the above embodiment, as shown in
In the above examples, the first particle was a CTC and the second particle was a red blood cell, white blood cell, and platelet, but the combination of the first and second particles is not limited to this. For example, the first particle could be an extracellular vesicle such as an exosome and the second particle could be a protein or debris smaller than the extracellular vesicle.
The first particle was the particle to be acquired and the second particle was the particle to be removed, however, not limited to this, the first particle may be a particle to be removed and the second particle may be a particle to be acquired. In this case, the first particle may still be separated from the second particle and the second particle may be acquired at a high throughput based on the size of the particles.
The first specimen inserted from inlet 101 was, but is not limited to, a blood specimen. As long as there are two types of particles of different sizes in the first specimen and these two types of particles may be separated by the particle separation chip 1, the first specimen may be a body fluid other than blood (cerebrospinal fluid, ascites, pleural fluid, synovial fluid, peritoneal dialysis drainage fluid, etc.), a specimen prepared from a body fluid, urine or a specimen prepared from urine.
The embodiments may be modified in various ways as appropriate within the scope of the technical ideas.
According to one or more embodiments, it may be possible to provide a particle separation chip and a particle separation apparatus that may demonstrate sufficient specimen processing capacity (throughput) at product development sites and clinical sites.
As a supplementary note, a sample measuring apparatus, an information reading apparatus, and an information reading method are summarized.
A particle separation chip that separates particles contained in a specimen based on particle size, comprising:
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
The branch flow path comprises the greater than or equal to 2 and less than or equal to 15,000 flow paths that are connected to the main flow path at each of the branches.
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
In the particle separation chip,
A particle separation apparatus comprising:
Number | Date | Country | Kind |
---|---|---|---|
2023-103519 | Jun 2023 | JP | national |